close
read more
Our company
Governance
Global presence
Key figures
Story
Vocation and values
Culture
Financial Results
Servier Institute
Our Products
Servier medicines
Generic drugs
e-Health solutions
Fight against counterfeiting
Areas of expertise
Research & Development
Research Axes
Development portfolio
Clinical trials
Paediatric expertise
Regulatory affairs
Pharmacovigilance
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Business development & licensing
Cross-functional activities
Our commitments
Patient In
Ethics
Compliance policy
CSR approach
Servier endowment fund
Newsroom
News
Press release
Insight
Medical publishing
FR
NEWS
ROOM
News
Press release
Insight
Medical publishing
Understanding the human microbiota: essential microorganisms
21 / 03 / 2019
Insight
Lupus: a rare disease that affects women
28 / 02 / 2019
Insight
Hypertension: a silent killer
10 / 12 / 2018
Insight
The hope of CAR-T, living drugs against cancers
16 / 10 / 2018
Insight
Action on cancer: Servier fighting on three promising fronts
05 / 09 / 2018
Insight
Understanding angina pectoris
23 / 08 / 2018
Insight
Understanding apoptosis: programmed cell death
22 / 08 / 2018
Insight
Understanding multiple sclerosis
23 / 05 / 2018
Insight
Understanding therapeutic targeting
15 / 04 / 2018
Insight
Understanding diabetes
20 / 12 / 2017
Insight
Changes in our understanding of cancer
07 / 10 / 2017
Insight
Understanding colorectal cancer
04 / 05 / 2017
Insight
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
No
Read more